Efficacy and analgesic use during the therapy of iatrogenic pneumothorax using Pleuralvent (TM) and Chest Tube (ASPIRATE): A randomised controlled trial protocol
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F20%3A10412614" target="_blank" >RIV/00216208:11110/20:10412614 - isvavai.cz</a>
Alternative codes found
RIV/00064190:_____/20:N0000062
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=UHDX08K5eC" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=UHDX08K5eC</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5507/bp.2020.008" target="_blank" >10.5507/bp.2020.008</a>
Alternative languages
Result language
angličtina
Original language name
Efficacy and analgesic use during the therapy of iatrogenic pneumothorax using Pleuralvent (TM) and Chest Tube (ASPIRATE): A randomised controlled trial protocol
Original language description
Background: Iatrogenic pneumothorax is a common complication of various diagnostic and therapeutic procedures such as transbronchial lung biopsies. The classical mode of treatment is chest tube insertion. Pneumothorax devices are now available on the market but there is a dearth of data on their efficacy to treat iatrogenic pneumothorax. It is important to provide such data as the pathophysiology of iatrogenic pneumothorax is different in comparison with spontaneous pneumothorax for which some data is available. Methods: This is a randomized, non-blinded, actively controlled trial of effectivity of iatrogenic pneumothorax treatment using the Pleuralvent(TM) device and chest tube insertion (16F). The secondary aim is to compare the overall pain level and the need for analgesic treatment in both treatment arms. We are planning to enrol 126 patients (63 in each treatment arm). Discussion: Preliminary results showed similar effectivity of the Pleuralvent(TM) system compared to large bore chest tube insertion. This randomized clinical trial should confirm these results and prove that the Pleuralvent(TM) system is an effective way of treatment of patients with iatrogenic pneumothorax. If Pleuralvent(TM) proves to have the same level of efficacy, it may become the standard of care of patients with iatrogenic pneumothorax.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30203 - Respiratory systems
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Biomedical Papers
ISSN
1213-8118
e-ISSN
—
Volume of the periodical
164
Issue of the periodical within the volume
2
Country of publishing house
CZ - CZECH REPUBLIC
Number of pages
3
Pages from-to
213-215
UT code for WoS article
000542635800015
EID of the result in the Scopus database
2-s2.0-85086659229